The Clinical Trial for Evaluation of Efficacy and Safety of DWP05195 in Postherpetic Neuralgia: Double-blind, Placebo-controlled, Randomized, Multi-center, Exploratory Clinical Trial.

Trial Profile

The Clinical Trial for Evaluation of Efficacy and Safety of DWP05195 in Postherpetic Neuralgia: Double-blind, Placebo-controlled, Randomized, Multi-center, Exploratory Clinical Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Apr 2014

At a glance

  • Drugs DWP 05195 (Primary)
  • Indications Neuropathic pain; Postherpetic neuralgia
  • Focus Therapeutic Use
  • Sponsors Daewoong Pharmaceutical
  • Most Recent Events

    • 20 Feb 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Mar 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
    • 15 Mar 2012 Planned End Date 1 Feb 2013 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top